Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The Role of CXCR4 Inhibitors as Novel Antiangiogenesis Agents in Cancer Therapy

The Role of CXCR4 Inhibitors as Novel Antiangiogenesis Agents in Cancer Therapy. ASH. 2004.


© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.